Jul 28, 2013

Vasaka - Adathodai




Common Name: Adulsa, Malabar Nut
Botanical Name: Justicia Adhatoda, Adhatoda Vasica Nees
Sanskrit: Vasaka
Hindi: Adosa, Arusha, Rus, Bansa
Tamil: Adathodai
Malayalam: Atalotakam
Bengali: Adulsa, Bakash,Vasok
Gujarati: Aradusī, Adulso, Aduraspee, Bansa
Kannada: Adusogae
Marathi: Adulsa, Adusa
Oriya: Basanga
Punjabi: Bhekkar
Telugu: Adamkabu, Adampaka, Addasaram

Part used : Leaves

Energetics :
- Rasa (taste): Bitter, Astringent
- Virya (action): Cold
- Vipaka (post-digestive effect): Pungent
- Guna (quality): Light, Dry

Action :
Broncho-dilator, expectorant, alterative, styptic, uterine contractor, alleviates breathing difficulties, prevents bleeding diseases, heart and lungs tonic, anti-asthmatic, spasmolytic, anti-inflammatory, purifies the blood, reduces fever.

Indications :

LUNGS :
It is a specific for respiratory congestion and wheezing. As a powerful bronchodilator it eases breathlessness and bronchiospasm. It clears inflammatory pitta heat and congestive kapha. It can be used where there is inflammation from an allergic response. It clears the lungs and nostrils. As it disperses stagnation and is strongly scatters Pranavayu it can aggravate Vata.

BLOOD : 
It is eulogised in the Sanskrit literature as superb for stopping bleeding. 
It astringes the mucus membranes and is effective for bleeding from ulcers, metrorrhagia, menorrhagia, epistaxis and the gums.

GYNAECOLOGY : 
Its astringency causes contraction of the uterus. 
Useful in bleeding and prolapse.

It is exceptionally powerful and should only be used under the guidance of a herbalist.

Contraindications :
- Pregnancy
- High vata




Dosage :
1/2 to 1 teaspoon per day before breakfast mixed with warm water. 


Note: Siddha treatment is based on complete physical examination of the patient, Naadi diagnosis, and other diagnostic criteria of the disease. The content given in this article is purely meant for information and education purpose only. Kindly consult a Siddha physician before any sort of self medication.

No comments: